Treating complex skin concerns often means balancing patient comfort, clinical results, and practice efficiency. That challenge grows when patients present with more than one issue at once, such as rosacea, vascular redness, acne, scars, pigment, or melasma. Many devices focus on one need well, but fall short when asked to do more.
ADVATx is built to solve that problem. This dual wavelength laser platform combines 589nm and 1319nm wavelengths in one system to support treatment across a wide range of common aesthetic indications. With 25 FDA/CE-cleared indications, suitability for virtually all skin types including skin of color, and the ability to treat patients year-round, it offers a flexible option for modern practices. In this overview, we’ll look at how the technology works, why the dual wavelength design matters, and how it supports outcomes in vascular concerns, rosacea, acne, scars, pigment, Skin Rejuvenation, and melasma.
Why Dual Wavelength Technology Matters
Many skin concerns do not exist in isolation. A patient may have persistent facial redness, post-acne pigment, textural changes, and early signs of aging at the same time. A platform that can address multiple layers of skin biology can make treatment planning more precise and more efficient.
ADVATx uses two complementary wavelengths:
589nm for Surface-Level Targeting
The 589nm wavelength is preferentially absorbed by oxyhemoglobin and also targets c. acne bacteria and pigmented lesions. This makes it especially relevant for:
In practical terms, this wavelength helps target visible redness and discoloration closer to the skin surface.
1319nm for Dermal Remodeling
The 1319nm wavelength penetrates deeper and is preferentially absorbed by water. It supports fibroblast stimulation and collagen production for non-ablative resurfacing. It also creates thermal impact in sebaceous glands, which can help regulate oil production.
This is where ADVATx expands beyond redness alone and supports:
Here’s why this matters: when you combine surface targeting with deeper dermal remodeling, you create a more complete treatment approach in one platform.
One Platform for Multiple High-Demand Indications
ADVATx is positioned as a foundational device because it supports treatment across a broad set of patient needs. For practices, that means fewer compromises. For patients, it can mean a clearer path from consultation to treatment.
Supporting Vascular and Rosacea Treatments
Persistent redness, facial veins, and flushing can be difficult to manage with general-purpose devices. ADVATx’s 589nm wavelength is designed to address these vascular features with precision, making it a strong option for rosacea and related redness concerns.
Addressing Acne, Scars, and Pigment
ADVATx also supports active acne through dual wavelength action. While 589nm helps target acne-related bacteria, 1319nm contributes to sebaceous gland heating and dermal repair. That combination can also support improvement in scars and post-inflammatory pigment.
Expanding Into Skin Rejuvenation and Melasma
Because the 1319nm wavelength promotes collagen remodeling, the platform also supports Skin Rejuvenation. At the same time, 589nm helps address pigmented lesions and melasma, creating a broader treatment profile that aligns with what many patients seek in real-world practice.
Designed for Patient Comfort and Practice Efficiency
Technology matters, but so does the treatment experience. ADVATx delivers both wavelengths through a single ergonomic handpiece, helping simplify workflow for providers. The addition of passive cooling with a sapphire tip supports comfort during treatment.
The platform is also designed with a strong safety profile in mind, with minimal side effects, no social downtime, and treatment suitability for virtually all skin types, including skin of color. For practices, another key benefit is simple economics: no consumables.
A Smarter Overview for Modern Aesthetic Practices
ADVATx brings together versatility, patient comfort, and practice efficiency in one dual wavelength platform. By combining 589nm and 1319nm technology, it supports treatment of vascular concerns, rosacea, acne, scars, pigment, Skin Rejuvenation, and melasma without forcing providers to rely on multiple devices. With 25 FDA/CE-cleared indications, year-round usability, and no consumables, it offers clear value for both clinics and patients.
Now is the time to see what ADVATx can do for your practice, explore the platform, assess its fit for your treatment mix, and discover how it can help you meet rising patient demand with confidence. Contact us today.
